340 related articles for article (PubMed ID: 24152262)
1. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
[TBL] [Abstract][Full Text] [Related]
2. Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.
Mitchell JM
Health Aff (Millwood); 2012 Apr; 31(4):741-9. PubMed ID: 22492891
[TBL] [Abstract][Full Text] [Related]
3. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
Penson DF
J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
[No Abstract] [Full Text] [Related]
4. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.
Falit BP; Gross CP; Roberts KB
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1285-8. PubMed ID: 20338470
[No Abstract] [Full Text] [Related]
5. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
Schilling PJ
Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
[TBL] [Abstract][Full Text] [Related]
6. Response to "Integrated prostate cancer centers and overutilization of IMRT: a close look at fee-for-service medicine in radiation oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).
Zimberg SH; Olsson CA
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1607; author reply 1607-8. PubMed ID: 21092840
[No Abstract] [Full Text] [Related]
7. Medicare fee reductions and the overuse of intensity-modulated radiotherapy.
Howard DH; Hockenberry J
Health Serv Res; 2021 Aug; 56(4):626-634. PubMed ID: 33905136
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation therapy for prostate cancer.
Jacobs BL; Schroeck FR; Hollenbeck BK
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521127
[No Abstract] [Full Text] [Related]
9. Intensity-modulated radiation therapy for prostate cancer.
Sartor O; Silberstein JL
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521126
[No Abstract] [Full Text] [Related]
10. Intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2014 Feb; 370(7):679-80. PubMed ID: 24521125
[No Abstract] [Full Text] [Related]
11. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
[TBL] [Abstract][Full Text] [Related]
12. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: IMRT treatment rates increase with urologist self-referral.
Phillips R
Nat Rev Urol; 2013 Dec; 10(12):680. PubMed ID: 24217677
[No Abstract] [Full Text] [Related]
14. Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.
Shahinian VB; Kaufman SR; Yan P; Herrel LA; Borza T; Hollenbeck BK
Medicine (Baltimore); 2017 Jun; 96(25):e6929. PubMed ID: 28640073
[TBL] [Abstract][Full Text] [Related]
15. Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer.
Quek RG; Master VA; Portier KM; Ward KC; Lin CC; Virgo KS; Lipscomb J
Urol Oncol; 2014 Aug; 32(6):748-60. PubMed ID: 24840868
[TBL] [Abstract][Full Text] [Related]
16. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
[TBL] [Abstract][Full Text] [Related]
17. Documenting Horizontal Integration Among Urologists Who Treat Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care Res Rev; 2022 Feb; 79(1):141-150. PubMed ID: 33331217
[TBL] [Abstract][Full Text] [Related]
18. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
[TBL] [Abstract][Full Text] [Related]
20. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
Vora SA; Wong WW; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
J Urol; 2013 Aug; 190(2):521-6. PubMed ID: 23415964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
